Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications
Outcomes with imetelstat in myelofibrosis: a systematic review and meta-analysis.
Journal: Leukemia & lymphoma
Published: October 15, 2025
Telomerase inhibitors - TMPyP4, BIBR 1532 and imetelstat - alter the adhesion potential of breast cancer MCF7 and MDA-MB-231 cells that leads to impaired ability to form spheroids.
Journal: Cell adhesion & migration
Published: October 14, 2025
Plain language summary of IMerge, a Phase 3 study of imetelstat versus placebo in people with lower-risk myelodysplastic syndromes and anemia.
Journal: Future oncology (London, England)
Published: October 13, 2025
Using imetelstat for lower-risk myelodysplastic syndromes.
Journal: Clinical advances in hematology & oncology : H&O
Published: October 06, 2025
Imetelstat: A First-in-Class Telomerase Inhibitor for the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes and Anemia.
Journal: Journal of the advanced practitioner in oncology
Published: August 11, 2025
Management of Anemia in Lower-Risk Myelodysplastic Syndromes/Neoplasms With Novel Agents.
Journal: JCO oncology practice
Published: August 05, 2025
Advances and Challenges in the Management of Myelodysplastic Syndromes.
Journal: Cancers
Published: June 26, 2025
Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes.
Journal: Blood research
Published: June 13, 2025
New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 07, 2025
Beyond Hypomethylating Agents: Novel Therapies and Targeted Approaches.
Journal: Clinical hematology international
Published: April 18, 2025
Imetelstat in myeloid malignancies: current data and future directions.
Journal: Expert review of anticancer therapy
Published: March 21, 2025
Last Updated: 10/31/2025